|
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov. |
NIDA-CTN-0049
This study is a three-group randomized, prospective trial. HIV-infected patients admitted for in-patient care who report having recently used opioids and/or stimulants and/or heavy alcohol in the past 12 months are eligible. Patients will be randomized to one of the following three groups: 1) Patient Navigator intervention, 2) Patient Navigator plus Contingency Management intervention, and 3) Treatment as Usual.
Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.